Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)

NCT02282293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Malaria
Human Immunodeficiency Virus

Interventions

DRUG: Monthly dihydroartemisinin-piperaquine (DP) + daily trimethoprim/sulfamethoxazole (TS)
DRUG: Monthly placebo + daily trimethoprim/sulfamethoxazole (TS)

Sponsor

University of California, San Francisco

Collaborators

[object Object]